comprehensive
Previous article:
The high cost of giving birth even with insurance
Next article: ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug
Next article: ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug
hotspot
focus
-
Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds
2025-09-28 21:02 -
Letters to First Opinion on caregivers, digital health, and more
2025-09-28 20:55 -
STAT Virtual Event: Putting AI to the Test
2025-09-28 20:47 -
Innovation in antibiotics is ailing. 'Brain drain' may kill it
2025-09-28 20:47 -
Thermo Fisher plant for manufacturing gene therapies to expand
2025-09-28 20:11 -
NIH documents show early flaws of $1.6 billion long Covid program
2025-09-28 19:04